The Biggest Peptide Breakthroughs of 2026: MOTS-c, Retatrutide, FDA Shifts & What Happens Next
The peptide landscape is evolving faster than ever before — and 2026 may prove to be the biggest turning point yet.
In this episode, Dr. Mike Belkowski breaks down the most important developments shaping the future of peptide science, longevity, metabolism, and mitochondrial medicine.
From major FDA regulatory changes and groundbreaking clinical trials to the next generation of GLP-1 drugs, mitochondrial peptides, amylin agonists, oral peptide therapeutics, and the latest pharmaceutical breakthroughs, this episode explores where peptide medicine is headed over the next several years.
You'll…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.